Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
33.98
+1.45 (4.46%)
Nov 1, 2024, 4:00 PM EDT - Market closed

Spyre Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
-0.892.3318.74--
Upgrade
Revenue Growth (YoY)
--61.96%-87.57%---
Upgrade
Cost of Revenue
84.0584.0558.5857.0759.6464.6
Upgrade
Gross Profit
-84.05-83.16-56.25-38.33-59.64-64.6
Upgrade
Selling, General & Admin
47.0134.4528.5327.3221.8415.73
Upgrade
Research & Development
41.86-----
Upgrade
Operating Expenses
88.8734.4528.5327.3221.8415.73
Upgrade
Operating Income
-172.92-117.61-84.78-65.65-81.48-80.33
Upgrade
Interest & Investment Income
15.736.150.840.110.592.14
Upgrade
Other Non Operating Income (Expenses)
-45.5-102.66-0.01-0.12-0.01-0.06
Upgrade
EBT Excluding Unusual Items
-202.69-214.13-83.95-65.66-80.89-78.25
Upgrade
Merger & Restructuring Charges
--10.95----
Upgrade
Gain (Loss) on Sale of Assets
16.4516.45----
Upgrade
Pretax Income
-185.95-338.82-83.95-65.66-80.89-78.25
Upgrade
Income Tax Expense
0.04-0.03-0.140.14--
Upgrade
Net Income
-185.98-338.79-83.82-65.8-80.89-78.25
Upgrade
Net Income to Common
-185.98-338.79-83.82-65.8-80.89-78.25
Upgrade
Shares Outstanding (Basic)
2573321
Upgrade
Shares Outstanding (Diluted)
2573321
Upgrade
Shares Change (YoY)
570.50%104.59%28.19%23.18%67.05%53.44%
Upgrade
EPS (Basic)
-7.31-49.12-24.86-25.02-37.89-61.23
Upgrade
EPS (Diluted)
-7.31-49.12-24.86-25.02-37.89-61.23
Upgrade
Free Cash Flow
-156.42-99.91-80.18-54.29-80.06-67.18
Upgrade
Free Cash Flow Per Share
-6.14-14.49-23.78-20.64-37.50-52.57
Upgrade
Gross Margin
----204.55%--
Upgrade
Operating Margin
--13274.49%-3640.23%-350.33%--
Upgrade
Profit Margin
--38238.15%-3598.75%-351.14%--
Upgrade
Free Cash Flow Margin
--11276.52%-3442.77%-289.71%--
Upgrade
EBITDA
-172.55-116.87-83.21-64.07-80.49-79.92
Upgrade
D&A For EBITDA
0.370.741.571.5810.42
Upgrade
EBIT
-172.92-117.61-84.78-65.65-81.48-80.33
Upgrade
Revenue as Reported
-0.892.3318.74--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.